期刊文献+

表观遗传学机制在糖尿病肾病发生发展中的作用

The role of epigenetic mechanism in the occurrence and development of diabetic nephropathy
下载PDF
导出
摘要 表观遗传学是在传统遗传学基础上发展而来的,它是不涉及DNA序列变化表型却发生可遗传基因改变的一门不同于遗传学的学科,其异常可能会影响疾病的发生发展。在糖尿病肾病(DN)的纤维化、炎症、氧化应激、糖代谢及脂代谢紊乱等相关发病机制和疾病进展中,表观遗传学机制发挥着不可忽视的作用。本文就该机制进行综述,为将来可进行的分子相关研究、疾病的诊断及治疗策略提供新方向。 Epigenetics is developed from traditional genetics, a discipline distinct from genetics that does not involve DNA sequence changes phenotypes but heritable genetic alterations, whose abnormalities may affect disease development. Epigenetic mechanisms play a non-negligible role in the pathogenesis and disease progression associated with fibrosis, inflammation, oxidative stress, and disorders of glucose and lipid metabolism in diabetic nephropathy(DN). This paper reviews its mechanism to provide new directions for future molecularly relevant studies, disease diagnosis and treatment strategies that can be conducted.
作者 彭会巧 郝晓晓 吴亚靓 缪鋆鋆 PENG Hui-qiao;HAO Xiao-xiao;WU Ya-liang(Jiangsu Provincial Traditional Chinese Medicine Hospital Jiangbei Branch,Nanjing 211500,China)
出处 《中国实用医药》 2023年第1期158-162,共5页 China Practical Medicine
关键词 糖尿病肾病 表观遗传学 DNA甲基化 组蛋白修饰 Diabetic nephropathy Epigenetics DNA methylation Histone modification
  • 相关文献

参考文献1

二级参考文献47

  • 1Center for Disease Control and Prevention. National DiabetesFact Sheet. 2011. Available from: URL: http://www.cdc.gov/diabetes/pubs/factsheet11.htm.
  • 2International Diabetes Federation. IDF Diabetes Atlas. 6th ed.Available from: URL: http://www.idf.org/diabetesatlas/.
  • 3Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, HenryRR, Pratley R, Zinman B. Impaired fasting glucose and impairedglucose tolerance: implications for care. Diabetes Care 2007; 30:753-759 [PMID: 17327355 DOI: 10.2337/dc07-9920].
  • 4DeFronzo RA, Abdul-Ghani M. Assessment and treatment ofcardiovascular risk in prediabetes: impaired glucose tolerance andimpaired fasting glucose. Am J Cardiol 2011; 108: 3B-24B [PMID:21802577 DOI: 10.1016/j.amjcard.2011.03.013].
  • 5Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL,Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, CollinsVR, Hamman RF. Predictors of progression from impaired glucosetolerance to NIDDM: an analysis of six prospective studies. Diabetes1997; 46: 701-710 [PMID: 9075814 DOI: 10.2337/diab.46.4.701].
  • 6Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ,Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type2 diabetes: the American College of Sports Medicine and the AmericanDiabetes Association: joint position statement. Diabetes Care 2010; 33:e147-e16.
  • 7[PMID: 21115758 DOI: 10.2337/dc10-9990]7 Wren JD, Garner HR. Data-mining analysis suggests an epigeneticpathogenesis for type 2 diabetes. J Biomed Biotechnol 2005; 2005:104-112 [PMID: 16046815 DOI: 10.1155/JBB.2005.104].
  • 8Gallou-Kabani C, Junien C. Nutritional epigenomics of metabolicsyndrome: new perspective against the epidemic. Diabetes 2005; 54:1899-1906 [PMID: 15983188 DOI: 10.2337/diabetes.54.7.1899].
  • 9Gallou-Kabani C, Vig-A, Junien C. Lifelong circadian andepigenetic drifts in metabolic syndrome. Epigenetics 2007; 2:137-146 [PMID: 17965598 DOI: 10.4161/epi.2.3.4897].
  • 10Jirtle RL, Skinner MK. Environmental epigenomics and diseasesusceptibility. Nat Rev Genet 2007; 8: 253-262 [PMID: 17363974DOI: 10.1038/nrg2045].

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部